CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-16.97%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$9.02B
AUM Growth
-$307M
(-3.3%)
Cap. Flow
-$262M
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
20.75%
Holding
813
New
30
Increased
168
Reduced
3
Closed
20
Top Buys
| 1 |
Hilton Worldwide
HLT
|
$21.1M |
| 2 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$3.53M |
| 3 |
Invesco
IVZ
|
$1.52M |
| 4 |
Sony
SONY
|
$607K |
| 5 |
Microsoft
MSFT
|
$13K |
Top Sells
| 1 |
JD.com
JD
|
$27.3M |
| 2 |
MDCO
Medicines Co
MDCO
|
$13.3M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$12.5M |
| 4 |
Hewlett Packard
HPE
|
$11.3M |
| 5 |
INST
Instructure, Inc.
INST
|
$9.03M |
Sector Composition
| 1 | Healthcare | 30.92% |
| 2 | Technology | 19.77% |
| 3 | Financials | 10.21% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Communication Services | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Enanta Pharmaceuticals
ENTA
$189M
| $6.65M | 0.07% |
110,139
| – | – |
|
277
McKesson
MCK
$85.5B
| $6.63M | 0.07% |
49,057
| – | – |
|
278
Agilent Technologies
A
$36.5B
| $6.56M | 0.07% |
78,621
+12
| +0% | +$1K |
|
279
Sempra
SRE
$52.9B
| $6.54M | 0.07% |
88,388
| – | – |
|
280
Exelon
EXC
$43.9B
| $6.5M | 0.07% |
204,382
| – | – |
|
281
Progressive
PGR
$143B
| $6.42M | 0.07% |
90,740
| – | – |
|
282
Alaska Air
ALK
$7.28B
| $6.34M | 0.07% |
95,796
| – | – |
|
283
Pembina Pipeline
PBA
$22.1B
| $6.29M | 0.07% |
173,297
| – | – |
|
284
EOG Resources
EOG
$64.4B
| $6.25M | 0.07% |
76,335
| – | – |
|
285
Motorola Solutions
MSI
$79.8B
| $6.21M | 0.07% |
39,432
| – | – |
|
|
TWTR
286
DELISTED
Twitter, Inc.
TWTR
| $6.16M | 0.07% |
196,705
| – | – |
|
287
Xencor
XNCR
$610M
| $6.13M | 0.07% |
182,176
+24
| +0% | +$807 |
|
288
Zebra Technologies
ZBRA
$16B
| $6.11M | 0.07% |
24,486
+5
| +0% | +$1.25K |
|
289
Marsh & McLennan
MMC
$100B
| $6.11M | 0.07% |
56,111
| – | – |
|
290
CME Group
CME
$94.4B
| $6.1M | 0.07% |
31,064
| – | – |
|
291
Unum
UNM
$12.6B
| $6.06M | 0.07% |
212,406
| – | – |
|
292
Martin Marietta Materials
MLM
$37.5B
| $6.03M | 0.07% |
22,049
| – | – |
|
293
CytomX Therapeutics
CTMX
$376M
| $6.02M | 0.07% |
741,191
+47
| +0% | +$382 |
|
294
Occidental Petroleum
OXY
$45.2B
| $6.01M | 0.07% |
149,087
| – | – |
|
295
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $5.95M | 0.07% |
337,795
+74
| +0% | +$1.3K |
|
296
Church & Dwight Co
CHD
$23.3B
| $5.94M | 0.07% |
86,383
| – | – |
|
297
Illinois Tool Works
ITW
$77.6B
| $5.9M | 0.07% |
33,615
| – | – |
|
298
Akamai
AKAM
$11.3B
| $5.9M | 0.07% |
69,901
| – | – |
|
299
Manulife Financial
MFC
$52.1B
| $5.88M | 0.07% |
295,881
| – | – |
|
300
Crown Castle
CCI
$41.9B
| $5.81M | 0.06% |
41,774
| – | – |
|